搜索医学 AI 论文与资源

ICLR 2026 Poster accepted paper at ICLR 2026. Prior-data fitted networks (PFNs) have recently been proposed as a promising way to train tabular foundation models. PFNs are transformers that are pre-trained on synthetic data generated from a prespecified prior distribution and that enable Bayesian inference through in-context learning. In this paper, we introduce CausalFM, a comprehensive framework for training PFN-based foundation models in various causal inference settings. First, we formalize the construction of Bayesian priors for causal inference based on structural causal models (SCMs) in a principled way and derive necessary criteria for the validity of such priors. Building on this, we propose a novel family of prior distributions using causality-inspired Bayesian neural networks that enable CausalFM to perform Bayesian causal inference in various settings, including for back-door, front-door, and instrumental variable adjustment.

ICLR 2026 Poster accepted paper at ICLR 2026. Predicting individualized potential outcomes in sequential decision-making is central for optimizing therapeutic decisions in personalized medicine (e.g., which dosing sequence to give to a cancer patient). However, predicting potential out- comes over long horizons is notoriously difficult. Existing methods that break the curse of the horizon typically lack strong theoretical guarantees such as orthogonality and quasi-oracle efficiency. In this paper, we revisit the problem of predicting individualized potential outcomes in sequential decision-making (i.e., estimating Q-functions in Markov decision processes with observational data) through a causal inference lens.

ICLR 2026 Poster accepted paper at ICLR 2026. Estimating heterogeneous treatment effects (HTEs) in time-varying settings is particularly challenging, as the probability of observing certain treatment sequences decreases exponentially with longer prediction horizons. Thus, the observed data contain little support for many plausible treatment sequences, which creates severe overlap problems. Existing meta-learners for the time-varying setting typically assume adequate treatment overlap, and thus suffer from exploding estimation variance when the overlap is low. To address this problem, we introduce a novel overlap-weighted orthogonal WO meta-learner for estimating HTEs that targets regions in the observed data with high probability of receiving the interventional treatment sequences.

ICLR 2026 Poster accepted paper at ICLR 2026. Estimating heterogeneous treatment effects (HTEs) from right-censored survival data is critical in high-stakes applications such as precision medicine and individualized policy-making. Yet, the survival analysis setting poses unique challenges for HTE estimation due to censoring, unobserved counterfactuals, and complex identification assumptions. Despite recent advances, from causal survival forests to survival meta-learners and outcome imputation approaches, evaluation practices remain fragmented and inconsistent. We introduce SurvHTE‐Bench, the first comprehensive benchmark for HTE estimation with censored outcomes. The benchmark spans (i) a modular suite of synthetic datasets with known ground truth, systematically varying causal assumptions and survival dynamics, (ii) semi-synthetic datasets that pair real-world covariates with simulated treatments and outcomes, and (iii) real-world datasets from a twin study (with known ground truth) and from an HIV clinical trial.

ICLR 2026 Poster accepted paper at ICLR 2026. Estimating potential outcomes for treatments over time based on observational data is important for personalized decision-making in medicine. However, many existing methods for this task fail to properly adjust for time-varying confounding and thus yield biased estimates. There are only a few neural methods with proper adjustments, but these have inherent limitations (e.g., division by propensity scores that are often close to zero), which result in poor performance. As a remedy, we introduce the iterative G-computation network (IGC-Net). Our IGC-Net is a novel, neural end-to-end model which adjusts for time-varying confounding in order to estimate conditional average potential outcomes (CAPOs) over time.

This Nature Portfolio / npj Digital Medicine collection is open for submissions until 2027-04-30. It invites work at the intersection of computational drug repurposing, multimodal biomedical data, and AI, including omics, EHRs, real-world evidence, imaging, digital phenotyping, LLMs, graph neural networks, multimodal transformers, knowledge graphs, generative AI, causal inference, explainability, and clinical translation.